Prognose

Das durchschnittliche Kursziel der Analysten beträgt +19,66€(+110,94%). Der Median liegt bei +19,66€(+110,94%).

Scoring-Modelle

Core Scientific, Inc. (CORZ) Q1 2025 Earnings Call Transcript
Core Scientific, Inc. (NASDAQ:CORZ ) Q1 2025 Results Conference Call May 7, 2025 4:30 PM ET Company Participants Jon Charbonneau - Vice President, Investor Relations Adam Sullivan - CEO, President & Director Matt Brown - Chief Operating Officer Jim Nygaard - Chief Financial Officer Conference Call Participants Joe Flynn - Compass Point Research Brett Knoblauch - Cantor Fitzgerald Darren Aftahi - Roth MKM Nick Giles - B Riley John Todaro - Needham & Company Kevin Dede - H.C. Wainwright Paul Golding - Macquarie Capital Bill Papanastasiou - Keefe, Bruyette, & Woods Operator Good day, ladies and gentlemen, and welcome to Core Scientific First Quarter Fiscal Year 2025 Earnings Conference Call.» Mehr auf seekingalpha.com
Core Scientific, Inc. (CORZ) Reports Q1 Loss, Misses Revenue Estimates
Core Scientific, Inc. (CORZ) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.19 per share a year ago.» Mehr auf zacks.com
Analysts Estimate Core Scientific, Inc. (CORZ) to Report a Decline in Earnings: What to Look Out for
Core Scientific, Inc. (CORZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.» Mehr auf zacks.com

Im letzten Quartal hatte CORE SCIENTIFIC einen Umsatz von 73,51 Mio€ und ein Nettoeinkommen von 536,77 Mio€